Dihydropyrimidine dehydrogenase and orotate phosphoribosyltransferase in esophageal cancer patients: Correlation with clinicopathological factors and prognosis

Molecular Medicine Reports

Volumn 1, Issue 5, 2008, Pages 713-719

  Tsutani, Yasuhiro ^a   Yoshida, Kazuhiro ^a,b   Sanada, Yuichi ^a   Oeda, Mamoru ^a   Suzuki, Takahisa ^a   Hihara, Jun ^a   Morihito, Okada ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b GIFU UNIVERSITY   (Japan)

Author keywords

Esophageal cancer; Immunochemistry; Statistics; Survival analysis

Indexed keywords

ANTINEOPLASTIC AGENT; DIHYDROPYRIMIDINE DEHYDROGENASE; OROTATE PHOSPHORIBOSYLTRANSFERASE; THYMIDYLATE SYNTHASE;

ADULT; ARTICLE; CALCULATION; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CARCINOGENESIS; CLINICAL EVALUATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENZYME BLOOD LEVEL; ESOPHAGUS CANCER; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH VESSEL; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROTEIN EXPRESSION; SQUAMOUS CELL; TUMOR GROWTH; VEIN;

EID: 69549092420     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr_00000018     Document Type: Article

References (21)

1. Herskovic A, Martz K, Sarraf AM, Leichman L, Brindle J, Vaitkevicius V, Cooper J, Byhardt R, Davis L and Emami B: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326: 1593-1598, 1992.
2. Vanhoefer U, Rougier P, Wilke H, Ducreux MP, Lacave AJ, van Cutsem E, Planker M, Santos JG, Piedbois P, Paillot B, Bodenstein H, Schmoll HJ, Bleiberg H, Nordlinger B, Couvreur ML, Baron B and Wils JA: Final results of a randomized phase III trial of sequential high-dose methotrexate, fluorouracil, and doxorubicin versus etoposide, leucovorin, and fluorouracil versus infusional fluorouracil and cisplatin in advanced gastric cancer: A trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group. J Clin Oncol 18: 2648-2657, 2000. (Pubitemid 30465650)
3. Maughan TS, James RD, Kerr DJ, Ledermann JA, McArdle C, Seymour MT, Cohen D, Hopwood P, Johnston C and Stephens RJ: Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multi-centre randomized trial. Lancet 359: 1555-1563, 2002. (Pubitemid 34621120)
4. Langenbach RJ, Danenberg PV and Heidelgerger C: Thymidylate synthase: mechanism of inhibition by 5-fluoro-2 [prime]-deoxyuridylate. Biochem Biophys Res Commun 48: 1565-1571, 1972.
5. Peters GJ, Wilt CL, Triest B, Codacci-Pisanelli G, Johnston PG, Groeningen CJ and Pinedo HM: Thymidylate synthase and drug resistance. Eur J Cancer 31: 1299-1305, 1995.
6. Ichikawa W, Takahashi T, Suto K, Yamashita T, Nihei Z, Shirota Y, Shimizu M, Sasaki Y and Hirayama R: Thymidylate synthase predictive power is overcome by irinotecan combination therapy with S-1 for gastric cancer. Br J Cancer 91: 1245-1250, 2004. (Pubitemid 39424782)
7. Toriumi F, Kubota T, Saikawa Y, Yoshida M, Otani Y, Watanabe M, Kumai K and Kitajima M: Thymidylate synthetase (TS) genotype and TS/dihydropyrimidine dehydrogenase mRNA level as an indicator in determining chemosensitivity to 5-fluorouracil in advanced gastric carcinoma. Anticancer Res 24: 2455-2463, 2004. (Pubitemid 39166331)
8. Shintani Y, Ohta M, Hirabayashi H, Tanaka H, Iuchi K, Nakagawa K, Maeda H, Kido T, Miyoshi S and Matsuda H: Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA levels in tumor tissues and the efficacy of 5-fluorouracil in patients with non-small-cell lung cancer. Lung Cancer 45: 189-196, 2004. (Pubitemid 38891481)
9. Dong ZM, Cui YJ, Kuang G, Wang R, Yu FL and Zhang JH: Polymorphisms of thymidylate synthase gene and correlation of its protein expression to lymph node metastasis of esophageal squamous cell carcinoma. Ai Zheng 24: 1225-1229, 2005.
10. Noguchi T, Moriyama S, Wada S, Takeno S, Kimura Y, Uchida Y and Gabbert HE: High level concentration of pyrimidine nucleoside phosphorylase in esophageal squamous cell carcinoma but no correlation with clinicopathological parameters. Dis Esophagus 16: 307-311, 2003. (Pubitemid 38075589)
11. Tokunaga Y, Sasaki H and Saito T: Clinical role of orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine. Surgery 141: 346-353, 2007. (Pubitemid 46356434)
12. Shirasaka T, Shimamoto Y and Fukushima M: Inhibition by oxonic acid of gastrointestinal toxicity of 5-fluorouracil without loss of its antitumor activity in rats. Cancer Res 53: 4004-4009, 1993. (Pubitemid 23267702)
13. Inaba M, Mitsuhashi J, Sawada H, Miike N, Naoe Y, Daimon A, Koizumi K, Tsujimoto H and Fukushima M: Reduced activity of anabolizing enzymes in 5-fluorouracil-resistant human stomach cancer cells. Jpn J Cancer Res 87: 212-220, 1996. (Pubitemid 26099498)
14. Kanai F, Kawakami T, Hamada H, Sadata A, Yoshida Y, Tanaka T, Ohashi M, Tateishi K, Shiratori Y and Omata M: Adenovirus-mediated transduction of Escherichia coli uracil phosphoribosyltransferase gene sensitizes cancer cells to low concentrations of 5-fluorouracil. Cancer Res 58: 1946-1951, 1998.
15. Inaba M, Sawada H, Sadata A and Hamada H: Circumvention of 5-fluorouracil resistance in human stomach cancer cells by uracil phosphoribosyltransferase gene transduction. Jpn J Cancer Res 90: 349-354, 1999. (Pubitemid 29164026)
16. Mizutani Y, Wada H, Fukushima M, Yoshida O, Nakanishi H, Li YN and Miki T: Prognostic significance of orotate phosphoribosyltransferase activity in bladder carcinoma. Cancer 100: 723-731, 2004. (Pubitemid 38176849)
17. Sakamoto K, Sugimoto Y, Miyadera K, Oka T and Fukushima M: Preparation of anti-orotate phosphoribosyltransferase antibody and its application to immunochemical detection in human tumor cells. Int J Mol Med 16: 245-249, 2005.
18. Harpole DH, Moore MB, Herndon JE II, Aloia T, D'Amico TA, Sporn T, Parr A, Linoila I and Allegra C: The prognostic value of molecular marker analysis in patients treated with trimodality therapy for esophageal cancer. Clin Cancer Res 7: 562-569, 2001. (Pubitemid 32707979)
19. Shigeoka H and Shiozaki H: Surgery for resectable esophageal cancer in Japan. Ann Thorac Cardiovasc Surg 10: 69-70, 2004.
20. Kamoshida S, Shiogama K, Shimomura R, Inada K, Sakurai Y, Ochiai M, Matuoka H, Maeda K and Tsutsumi Y: Immunohistochemical demonstration of fluoropyrimidine-metabolizing enzymes in various types of cancer. Oncol Rep 14: 1223-1230, 2005.
21. Mizutani Y, Wada H, Yoshida O, Fukushima M, Nakanishi H and Miki T: Significance of orotate phosphoribosyltransferase activity in renal cell carcinoma. J Urol 171: 605-610, 2004. (Pubitemid 38090440)